[1] F. Bray, J. Ferlay, I. Soerjomataram, R.L. Siegel, L.A. Torre and A. Jemal, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin68 (2018), 394-424.
[2] F. Perrotti, C. Rosa, I. Cicalini, P. Sacchetta, P. Del Boccio, D. Genovesi and D. Pieragostino, Advances in Lipidomics for Cancer Biomarkers Discovery, Int J Mol Sci17 (2016).
[3] K.M. Nieman, H.A. Kenny, C.V. Penicka, A. Ladanyi, R. Buell-Gutbrod, M.R. Zillhardt, I.L. Romero, M.S. Carey, G.B. Mills, G.S. Hotamisligil, S.D. Yamada, M.E. Peter, K. Gwin and E. Lengyel, Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth, Nat Med17 (2011), 1498-503.
[4] K. Lindemann, L.J. Vatten, M. Ellstrom-Engh and A. Eskild, Serum lipids and endometrial cancer risk: results from the HUNT-II study, Int J Cancer124 (2009), 2938-41.
[5] C. Agnoli, S. Grioni, S. Sieri, C. Sacerdote, P. Vineis, R. Tumino, M.C. Giurdanella, V. Pala, A. Mattiello, P. Chiodini, L. Iacoviello, A. De Curtis, L. Cattaneo, F.J. van Duijnhoven, S. Panico and V. Krogh, Colorectal cancer risk and dyslipidemia: a case-cohort study nested in an Italian multicentre cohort, Cancer Epidemiol38 (2014), 144-51.
[6] L. Wuermli, M. Joerger, S. Henz, H.P. Schmid, W.F. Riesen, G. Thomas, W. Krek, T. Cerny and S. Gillessen, Hypertriglyceridemia as a possible risk factor for prostate cancer, Prostate Cancer Prostatic Dis8 (2005), 316-20.
[7] R. Arthur, H. Moller, H. Garmo, L. Holmberg, P. Stattin, H. Malmstrom, M. Lambe, N. Hammar, G. Walldius, D. Robinson, I. Jungner and M.V. Hemelrijck, Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories, Cancer Med5 (2016), 1307-18.
[8] K. Raju, S.S. Punnayanapalya, N. Mariyappa, S.M. Eshwarappa, C. Anjaneya and L.J. Kai, Significance of the plasma lipid profile in cases of carcinoma of cervix: a tertiary hospital based study, Asian Pac J Cancer Prev15 (2014), 3779-84.
[9] Y. Sun, H. Meng, Y. Jin, X. Shi, Y. Wu, D. Fan, X. Wang, X. Jia and H. Dai, Serum lipid profile in gynecologic tumors: a retrospective clinical study of 1,550 patients, Eur J Gynaecol Oncol37 (2016), 348-52.
[10] Q. Tang, Q.Y. Hu, Y.F. Piao and Y.H. Hua, Correlation between pretreatment serum LDL-cholesterol levels and prognosis in nasopharyngeal carcinoma patients, Onco Targets Ther9 (2016), 2585-91.
[11] F. Zhu, X. Xu, B. Shi, L. Zeng, L. Wang, X. Wu and H. Zhu, The positive predictive value of low-density lipoprotein for recurrence-free survival in ovarian cancer, Int J Gynaecol Obstet143 (2018), 232-238.
[12] P.D. Chi, W. Liu, H. Chen, J.P. Zhang, Y. Lin, X. Zheng, W. Liu and S. Dai, High-density lipoprotein cholesterol is a favorable prognostic factor and negatively correlated with C-reactive protein level in non-small cell lung carcinoma, PLoS One9 (2014), e91080.
[13] Y. Fan, X. Ding, J. Wang, F. Ma, P. Yuan, Q. Li, P. Zhang and B. Xu, Decreased serum HDL at initial diagnosis correlates with worse outcomes for triple-negative breast cancer but not non-TNBCs, Int J Biol Markers30 (2015), e200-7.
[14] W.A. Peters, 3rd, P.Y. Liu, R.J. Barrett, 2nd, R.J. Stock, B.J. Monk, J.S. Berek, L. Souhami, P. Grigsby, W. Gordon, Jr. and D.S. Alberts, Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix, J Clin Oncol18 (2000), 1606-13.
[15] M. Rotman, A. Sedlis, M.R. Piedmonte, B. Bundy, S.S. Lentz, L.I. Muderspach and R.J. Zaino, A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study, Int J Radiat Oncol Biol Phys65 (2006), 169-76.
[16] C. Vernieri, S. Casola, M. Foiani, F. Pietrantonio, F. de Braud and V. Longo, Targeting Cancer Metabolism: Dietary and Pharmacologic Interventions, Cancer Discov6 (2016), 1315-1333.
[17] M.J. Chapman, H.N. Ginsberg, P. Amarenco, F. Andreotti, J. Boren, A.L. Catapano, O.S. Descamps, E. Fisher, P.T. Kovanen, J.A. Kuivenhoven, P. Lesnik, L. Masana, B.G. Nordestgaard, K.K. Ray, Z. Reiner, M.R. Taskinen, L. Tokgozoglu, A. Tybjaerg-Hansen, G.F. Watts and P. European Atherosclerosis Society Consensus, Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management, Eur Heart J32 (2011), 1345-61.
[18] H. Ulmer, W. Borena, K. Rapp, J. Klenk, A. Strasak, G. Diem, H. Concin and G. Nagel, Serum triglyceride concentrations and cancer risk in a large cohort study in Austria, Br J Cancer101 (2009), 1202-6.
[19] H. Tulinius, N. Sigfusson, H. Sigvaldason, K. Bjarnadottir and L. Tryggvadottir, Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders, Cancer Epidemiol Biomarkers Prev6 (1997), 863-73.
[20] X. Yang, R.C. Ma, W.Y. So, L.W. Yu, A.P. Kong, G.T. Ko, G. Xu, R. Ozaki, P.C. Tong and J.C. Chan, Low triglyceride and nonuse of statins is associated with cancer in type 2 diabetes mellitus: the Hong Kong Diabetes Registry, Cancer117 (2011), 862-71.
[21] E.H. Allott, L.E. Howard, M.R. Cooperberg, C.J. Kane, W.J. Aronson, M.K. Terris, C.L. Amling and S.J. Freedland, Serum lipid profile and risk of prostate cancer recurrence: Results from the SEARCH database, Cancer Epidemiol Biomarkers Prev23 (2014), 2349-56.
[22] T. Lofterod, E.S. Mortensen, H. Nalwoga, T. Wilsgaard, H. Frydenberg, T. Risberg, A.E. Eggen, A. McTiernan, S. Aziz, E.A. Wist, A. Stensvold, J.B. Reitan, L.A. Akslen and I. Thune, Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes, BMC Cancer18 (2018), 654.
[23] C. Vernieri, S. Pusceddu, G. Fuca, P. Indelicato, G. Centonze, L. Castagnoli, E. Ferrari, A. Ajazi, S. Pupa, S. Casola, M. Foiani, V. Mazzaferro, G. Pruneri, M. Milione and F. de Braud, Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs), Int J Cancer144 (2019), 1704-1712.